J&J's Talcum Powder Goes on Trial in Ovarian Cancer LawsuitsBy , , and
Company asserts safety of products containing cosmetic talc
St. Louis trial's outcome could determine fate of 1,200 cases
Johnson & Johnson, already facing lawsuits over products from surgical mesh to antipsychotic drugs, began trial Tuesday over claims the talcum powder it marketed to women gave some of them cancer.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.